Koenig & Bauer's €1 Billion Backlog: Real Order Strength or Just a Comforting Number?

Q1 improved the order picture, but Q2 has to prove profit conversion

Koenig & Bauer's backlog has cleared the €1 billion mark, but that number only matters if it translates into earnings. In Q1, the company posted a book-to-bill ratio of 1.14, order intake rose 21.4% to €297.6m, and sales increased 3.2% to €260.2m. Those are constructive signs, but they are not the same as full earnings conversion.

A large backlog can cushion the next few quarters, yet it does not justify a higher multiple on its own. Management has already set a clear benchmark: stable Group revenue at previous year's level (~€1.3bn) and operating EBITDA of approximately €80m for 2026. The market now needs evidence that orders are turning into revenue and margins, not just a full pipeline.

The cash-flow picture reinforces that point. Last year ended with positive free cash flow of €7.3m, showing the business can generate cash when things work. But Q1 2026 also showed EBITDA came to -2.9 million euros. That gap is why Q2 matters: investors need proof that the order strength is becoming operating profit.

S&T looks like the stronger driver, while P&P still needs to prove it can contribute

The key question is not whether Koenig & Bauer is taking in more orders. It is whether those orders reflect durable demand and better profitability across the business.

S&T is showing the most credible recovery

The clearest positive signal is S&T. Sales rose 24.1% to 134 million euros, order intake increased 40.6% to €114.7m, and the segment returned to positive operating profit with EBITDA of €4.1m. Seeing growth in orders, revenue, and profitability at the same time is the strongest signal in the release.

That quarter also fits the broader 2025 trend. Last year, S&T revenue increased +6.8% to €596.0m. That does not make the segment risk-free, but it does suggest the improvement is broader than a single quarter.

P&P remains the part of the story that needs confirmation

The available evidence does not yet show the same all-around improvement in P&P. The broader Q1 picture still included EBITDA came to -2.9 million euros at group level, and management described a two-tier momentum in which S&T is advancing while P&P still faces market pressure. That means investors should not assume backlog strength is automatically becoming profitable shipment volume across the whole business.

There is also a useful reminder from last year. The backlog at the start of 2025 was €1,032.8 m, yet operating EBIT was still -€11.4m. A large order backlog did not automatically turn into earnings then, and it is reasonable to ask whether the same lesson still applies.

What would make the order strength more credible

Watch for a short list of signals in Q2:

• Broader profitability: S&T remains strong, and P&P starts contributing rather than dragging.
• Better conversion: revenue growth improves as shipments move ahead of the seasonal Q1 pattern.
• Clearer earnings power: profitability improves even after the one-off closure charges mentioned in Q1.

If those signals improve together, the backlog looks more like a real operating advantage. If not, it remains a reassuring headline rather than a full investment case.

What the market is really judging now

Koenig & Bauer does not need another order-story headline. It needs to show that the current backlog can support management's 2026 targets. The core benchmark is simple: can the company deliver stable Group revenue at previous year's level (~€1.3bn) and operating EBITDA of approximately €80m?

Investors already have a recent operating baseline. Last year, Group revenue reached €1,302.4m and operating EBIT was €36.6m, while the year also ended with positive free cash flow. That shows improvement is possible. The 2026 target is the next step, and Q2 is the first real test of whether order momentum can become margin progress.

The numbers that matter next

• Shipment conversion: does revenue improve from the seasonal Q1 base?
• Segment mix: does S&T keep being the clearest growth and profitability driver?
• P&P trajectory: does the segment move toward break-even or remain a drag?
• Guidance discipline: does management still support the €1.3bn revenue and roughly €80m EBITDA outlook as the year progresses?

If Q2 shows firmer revenue conversion and clearer margin progress, the backlog can become a real valuation support. If not, the stock is more likely to stay in a wait-and-see zone.